Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06868524 · ClinicalTrials.gov registry record · NA

Leading Healthy Eating and Activity Promotion Program

A NA study of Cancer and Cancer Survivor, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06868524 is a NA study of Cancer and Cancer Survivor that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06868524, a NA study of Cancer and Cancer Survivor, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goal of the LEAP project is to improve the health and well-being of cancer survivors and their co-survivors living in persistent poverty areas by providing healthy behavior change support. This will be done by engaging the community in adapting beneficial approaches for promoting healthy diet and regular physical activity into a program for cancer survivors and co-survivors that is appropriate for the persistent poverty context and social determinants of health.

Interventions

  • BEHAVIORAL LEAP Program

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-10-30
Est. Completion 2029-03-01
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06868524

The ClinicalTrials.gov registry entry for NCT06868524 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (97% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which LEAP Program is the first listed.

NCT06868524 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06868524 about?

NCT06868524 is a clinical study titled "Leading Healthy Eating and Activity Promotion Program". The goal of the LEAP project is to improve the health and well-being of cancer survivors and their co-survivors living in persistent poverty areas by providing healthy behavior change support. This will be done by engaging the community in adapting beneficial approaches for promoting healthy diet an...

What is the current status of trial NCT06868524?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-30. Estimated completion is 2029-03-01.

What conditions does trial NCT06868524 study?

This clinical trial studies the following conditions: Cancer, Cancer Survivor, Oncology.

What interventions are being tested in trial NCT06868524?

The interventions under investigation include: LEAP Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT06868524?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06868524 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.